Michael Astrue
Overview
Michael Astrue received an average of $204K in total compensation, including $87K in salary, at InVivo Therapeutics Holdings between 2013 and 2014.
Source: SEC filing on April 29, 2015.
Related executives
We found 16 more executives who work or worked at InVivo Therapeutics Holdings.
Richard Toselli
InVivo Therapeutics Holdings
Chief Executive Officer
Richard Christopher
InVivo Therapeutics Holdings
Chief Financial Officer
Heather Hamel
InVivo Therapeutics Holdings
Chief Legal Officer
Christopher McNulty
InVivo Therapeutics Holdings
Chief Financial Officer
Pamela Stahl
InVivo Therapeutics Holdings
Former Chief Commercial Officer
Mark Perrin
InVivo Therapeutics Holdings
Chief Executive Officer
Thomas Ulich
InVivo Therapeutics Holdings
Chief Scientific Officer
Tamara Joseph
InVivo Therapeutics Holdings